APT Medical (SHSE:688617) Total Liabilities: ¥499 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688617 APT Medical Inc SHSE:688617
78 GF Score
Price ¥239.60
GF Value ¥366.17
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is APT Medical Total Liabilities?

APT Medical SHSE:688617 -1.35% 78 Total Liabilities is ¥499 Mil as of Jun. 2026. GuruFocus rates SHSE:688617 with a GF Score™ of 78/100 and a GF Value™ of ¥366.17 (Significantly Undervalued). The stock has 1 warning sign investors should review.

APT Medical's Total Liabilities for the quarter that ended in Jun. 2026 was ¥499 Mil.

APT Medical's quarterly Total Liabilities declined from Dec. 2025 (¥521.51 Mil) to Mar. 2026 (¥423.40 Mil) but then increased from Mar. 2026 (¥423.40 Mil) to Jun. 2026 (¥498.89 Mil).

APT Medical's annual Total Liabilities declined from Dec. 2023 (¥610.98 Mil) to Dec. 2024 (¥425.85 Mil) but then increased from Dec. 2024 (¥425.85 Mil) to Dec. 2025 (¥521.51 Mil).

APT Medical Total Liabilities Historical Data

* Premium members only.

The historical data trend for APT Medical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

APT Medical Total Liabilities Chart

APT Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only 222.02 434.91 610.98 425.85 521.51

APT Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 393.22 423.50 521.51 423.40 498.89
SHSE:688617
78GF Score
APT Medical Inc SHSE:688617
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

APT Medical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

APT Medical's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=458.96+(11.571+50.976
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=522

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=3651.857-3130.349
=522

APT Medical's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=437.839+(4.578+56.468
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=499

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=3618.452-3119.566
=499

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ¥499 Mil mean?
APT Medical (SHSE:688617) has a Total Liabilities of ¥499 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for APT Medical and its competitors.
Is APT Medical's Total Liabilities too high?
APT Medical's current Total Liabilities is ¥499 Mil. Overall, APT Medical has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does APT Medical's Total Liabilities compare to ABT and SYK?
APT Medical's Total Liabilities of ¥499 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for APT Medical and its competitors. APT Medical's current Total Liabilities is ¥499 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is APT Medical stock overvalued right now?
Based on GuruFocus' analysis, APT Medical (SHSE:688617) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥366.17, compared to a current price of ¥239.60 — trading 34.6% below its estimated fair value. The current Total Liabilities is ¥499 Mil. APT Medical's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For APT Medical (SHSE:688617), the current Total Liabilities is ¥499 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is APT Medical (SHSE:688617) Overvalued in 2026?

Based on GuruFocus' analysis, APT Medical stock appears to be undervalued. The current stock price of ¥239.60 is trading 34.6% below its estimated GF Value™ of ¥366.17. GuruFocus considers APT Medical to be Significantly Undervalued.

Key valuation signals for SHSE:688617:

  • Total Liabilities: ¥499 Mil
  • GF Value™: ¥366.17 vs. price of ¥239.60 (34.6% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the SHSE:688617 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

APT Medical Business Description

Address No. 11, Songpingshan Langshan Road, Xili Street, Room 601, Building B, Tongfang Information Port, Songpingshan Community, Nanshan District, Guangdong Province, Shenzhen, CHN, 518000
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
78GF Score

Get the complete analysis for SHSE:688617

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥239.60
Price
¥366.17
GF Value